Quick Answer
Oncology Institute, Inc. reported Shares Outstanding of 98.86 million shares for fiscal year 2025.
Oncology Institute, Inc. Shares Outstanding — Annual History
| Fiscal Year | Shares Outstanding | YoY Change |
|---|---|---|
| 2025 | 98.86M | +30.5% |
| 2024 | 75.74M | +2.1% |
| 2023 | 74.15M | +1.2% |
| 2022 | 73.27M | +0.0% |
| 2021 | 73.25M | +1173.9% |
| 2020 | 5.75M | +0.0% |
| 2019 | 5.75M | — |
Quarterly Shares Outstanding
| Quarter Ending | Shares Outstanding | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | 97.57M | +29.1% | +4.6% |
| June 30, 2025 | 93.28M | +23.6% | +4.9% |
| March 31, 2025 | 88.93M | +19.7% | +17.4% |
| December 31, 2024 | 75.74M | +2.1% | +0.2% |
| September 30, 2024 | 75.56M | +2.5% | +0.1% |
| June 30, 2024 | 75.49M | +3.5% | +1.6% |
| March 31, 2024 | 74.31M | +0.8% | +0.2% |
| December 31, 2023 | 74.15M | +1.2% | +0.6% |
- Oncology Institute, Inc. showed an increase of +30.5% in Shares Outstanding compared to the prior fiscal year.
- Over the 2019–2025 period, Oncology Institute, Inc.’s shares outstanding has grown by 1619.4% (from 5.75 million shares to 98.86 million shares).
- The most recent figure is from Oncology Institute, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 12, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: